ITMCTR2200005923
Not yet recruiting
Phase 1
Evidence-based clinical research on the intervention of activating blood circulation and removing toxicity herbs in patients with borderline coronary lesions
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\)Patients with coronary artery bordeline lesions confirmed by coronary angiography or coronary computed tomographic angiography with stenosis of at least one major coronary artery lumen between 50% and 70%;
- •(2\) Patients aged 18–80 years.
- •(3\) Patients with heart function grading of NYHA grade?\-?
- •(4\) Patients conform to the TCM standard of blood stasis syndrome
- •(5\) Patients will be informed about the trial and should voluntarily sign the consent form.
Exclusion Criteria
- •(1\) Patients who had previously undergone coronary stent implantation, coronary artery bypass grafting or acute myocardial infarction within 3 months;
- •(2\) Patients with diffuse lesions throughout the diseased vessels;
- •(3\) Those who had previously undergone other cardiac operations, such as valve replacement;
- •(4\) Patients with severe heart, liver and renal insufficiency, who are not suitable for coronary angiography and related examination and treatment;
- •(5\) Persons suffering from mental disorders;
- •(6\) Persons suffering from hepatitis, tuberculosis, AIDS and other infectious diseases;
- •(7\) Allergic constitution;
- •(8\) Pregnant and lactating women;
- •(9\) Those whose life expectancy is less than one year;
- •(10\) Participated in other clinical researchers within the last 3 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study on evidence-based evaluation and therapeutic mechanism of integrated Chinese and Western medicine for treatment of diabetic foot -- An evidence-based evaluation of The combination of Rubber Shengji Paste and compound bromelain to promote the healing of the exposed wound of diabetic foot tendoITMCTR2100004318The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Completed
Not Applicable
Predictive factors for foot ulceration in diabetes: a follow-upFoot ulceration in diabetesNutritional, Metabolic, EndocrineFoot ulceration is assessed by reviewing electronic patient records at baseline.ISRCTN10550720HS Fife1,192
Recruiting
Not Applicable
Study on the curative effect and evidence-based evaluation of traditional Chinese medicine scheme for lumbar disc herniatioITMCTR2000003965Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Completed
Not Applicable
Clinical studies to confirm the efficacy and safety of synthetic bone marrow in bone fusion and bone graft treatment in patients with femur fractureKCT0004793Jeonbuk National University Hospital5
Recruiting
Phase 3
A confirmatory clinical study of ISN001 in patients with epidermolysis bullosaJPRN-jRCT2033210128Ishiko Akira8